In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ethypharm SA

www.ethypharm.com

Latest From Ethypharm SA

Manufacturing Round-Up: Sterling Gains A US Site As Normon Invests €100m

Sterling Pharma Solutions has acquired a US facility and Olon has bought a plant from Sandoz, while Normon is investing €100m in manufacturing expansions.

Manufacturing Compliance

China Investment Roundup: Strategic Overseas Moves Target Product Acquisitions

R&D-based big pharma groups in China with sufficient cash flow are increasing their strategic investments in overseas companies and products with an eye on entry to the global market, while start-ups continue to actively raise new funds from venture capitalists.

China Financing

Luye Looks To Horizons Beyond Pharma, China

Dianbo Liu, chairman of the Hong Kong listed Luye Group, talks about the company’s ambitious plans to become a global top 100 pharmaceutical company through innovation, acquisitions and overseas expansion, and to broaden its activities well beyond selling medicines to meet changing patient needs and industry pressures.

Companies China

Speculation Mounts Over Chinese Interest In Ethypharm

French firm Ethypharm’s portfolio in CNS and pain management is apparently attracting interest from Chinese and other pharma groups in a potential strategic acquisition, with Luye Pharma and Mundipharma emerging as possible bidders given their interest in M&A as a route to business expansion.

BioPharmaceutical Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Site Specific
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Ethypharm SA
  • Senior Management
  • Gerard Leduc, Chmn. & Pres.
  • Contact Info
  • Ethypharm SA
    Phone: (33) 1 41 12 17 20
    194 bureaux de la colline
    Batiment D
    Saint Cloud, 92213
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register